Increasing Global Focus on Precision Medicine and Sustainable Gene Editing Solutions

Gene editing market, valued at $4,852 million in 2024 and is projected to expand at a robust CAGR of 8.5% between 2025 and 2035, reaching an estimated value of $11,870 million by the end of the forecast period. Growing global emphasis on precision treatments and sustainable gene editing solutions, driven by rapid developments in genomics, bioinformatics, and healthcare technology. This rise is fueled by the increasing prevalence of chronic and genetic diseases and the rising demand for personalized therapies. Precision medicine leverages individual genetic, environmental, and lifestyle data to tailor treatments, and the integration of sustainable gene editing technologies is enabling more effective, targeted, and environmentally responsible solutions for both healthcare and agriculture. The best-known system in the genome editing toolbox is CRISPR/Cas9, for which Emmanuelle Charpentier and Jennifer Doudna, the inventors of the genetic scissors, received the Nobel Prize (Ledford & Callaway,?2020). For instance, in March 2022, the Indian Government signed the Office Memorandum ‘Exemption of the Genome Edited plants falling under the categories of SDN1 and SDN2 from the provisions of the Rules, 1989.

Browse the full report description of “Gene Editing Market Size, Share & Trends Analysis Report by Type (Reagents & Consumables, and Software & Systems), by Technology (CRISPR, TALENS, ZFN, Base Editing, Antisense, RNAI, Other Technologies), by Application (Cell Line Engineering, Genome Editing, Drug Discovery & Development, Other Applications), by End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROS & CDMOS, Other End Users) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/gene-editing-market

Key Players and Innovations

Several major players lead the gene editing market, including Agilent Technologies, Inc., GenScript, Merck KGaA, Precision BioSciences, Inc., and Thermo Fisher Scientific Inc., among others. These companies are at the forefront of innovation, rapidly developing new technologies to meet the industry's needs. Some of the recent developments in the market include-

• In January 2024, Beam Therapeutics announced the first participant in their US-based phase 1/2 trial of a base editing therapy for severe SCD.  The beam used base editing to turn on HbF. Base editing is a version of CRISPR-Cas9 technology that changes single DNA letters, or nucleotides, without creating double-stranded breaks in DNA, reducing certain safety risks.

• In December 2022, Ormond Street group reported treating a teenager with CAR-T cells made with base editing, it is a kind of CRISPR-based editing technology that can make small changes to DNA without creating a double-stranded DNA break. This was the first use of base editing in a clinical trial. The teen, Alyssa, was treated with base-edited anti-CD7 CAR-T cells, made from allogeneic, or donor, cells.

Market Coverage

• The market numbers available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Type

o By Technology

o By Application

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Agilent Technologies, Inc., GenScript, Merck KGaA, Precision BioSciences, Inc., and Thermo Fisher Scientific Inc., among others. 

Key Questions Addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Gene Editing Market Report Segment

By Type

• Reagents & Consumables
• Software & Systems

By Technology

• CRISPR
• TALENS
• ZFN
• Base Editing
• Antisense
• RNAI
• Other Technologies

By Application

• Cell Line Engineering
• Genome Editing
• Drug Discovery & Development
• Other Applications

By End-User 

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CROS & CDMOS
• Other End Users

Global Gene Editing Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gene-editing-market